Literature DB >> 8792104

High glycosylated hemoglobin levels increase the risk of progression to diabetes mellitus in subjects with glucose intolerance.

H Yoshinaga1, K Kosaka.   

Abstract

The relationships between HbA1c level and oral glucose tolerance test (OGTT) at the initial visit and the incidence of diabetes after 5 years of follow-up were investigated in 819 subjects participating in a general health examination. The 100 g OGTT was performed. In order to use WHO criteria, the blood glucose levels of 100 g OGTT corresponding to those of 75 g OGTT were adopted according to the recommendations of the Japan Diabetes Society. Subjects other than diabetic type and IGT (impaired glucose tolerance) were divided into a normal group (fasting blood glucose < 100 mg/dl, 1-h blood glucose < 160 mg/dl, a 2-h blood glucose < 120 mg/dl) and a borderline group (the remaining subjects). In IGT, the incidence of diabetes in the low- (< or = 6.3%), intermediate- (6.4-6.7%) and high-HbA1c (> of = 6.8%) groups were 10.4%, 23.1% and 52.5%, respectively (high vs intermediate and low, P < 0.001; intermediate vs low, P < 0.05). In the borderline group, the incidence were 2.8%, 14.3% and 28.6%, respectively (high and intermediate vs low, P < 0.001). The results showed that the combination of HbA1c level and OGTT enables more precise prediction of progression to NIDDM in subjects with glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792104     DOI: 10.1016/0168-8227(96)01195-3

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

2.  Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.

Authors:  Aruna D Pradhan; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

3.  The use of dried blood spot sampling in the national social life, health, and aging project.

Authors:  Sharon R Williams; Thomas W McDade
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-25       Impact factor: 4.077

Review 4.  A1C level and future risk of diabetes: a systematic review.

Authors:  Xuanping Zhang; Edward W Gregg; David F Williamson; Lawrence E Barker; William Thomas; Kai McKeever Bullard; Giuseppina Imperatore; Desmond E Williams; Ann L Albright
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

5.  Patterns of glycemic control using glycosylated hemoglobin in diabetics.

Authors:  Arunpreet Singh Kahlon; Rambha Pathak
Journal:  J Pharm Bioallied Sci       Date:  2011-07

6.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.